Vident Advisory, LLC Adma Biologics, Inc. Transaction History
Vident Advisory, LLC
- $6.84 Trillion
- Q1 2025
A detailed history of Vident Advisory, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Vident Advisory, LLC holds 137,875 shares of ADMA stock, worth $2.31 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
137,875Holding current value
$2.31 Million% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
404Shares Held
194MCall Options Held
2.55MPut Options Held
816K-
Vanguard Group Inc Valley Forge, PA21.4MShares$358 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$312 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$215 Million0.04% of portfolio
-
State Street Corp Boston, MA11.4MShares$192 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$99.1 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.29B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...